Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu
  • quotes

  • charts

  • technicals

  • company

Imagin Medical Inc. (IMEXF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1180 +35.59%
on 10/24/17
0.1930 -17.10%
on 11/03/17
+0.0332 (+26.18%)
since 10/20/17
3-Month
0.0360 +344.44%
on 08/31/17
0.1930 -17.10%
on 11/03/17
+0.1130 (+240.43%)
since 08/22/17
52-Week
0.0078 +1,951.28%
on 02/10/17
0.1930 -17.10%
on 11/03/17
+0.1094 (+216.21%)
since 11/18/16

Most Recent Stories

More News
Unsure About Biotech Gains Then Consider Medical Innovation Instead

While biotech and pharmaceutical firms may be taking the focus right now, for those unsure about the risk, medical device companies continue to provide some truly innovative offerings.

SNN : 35.79 (+0.59%)
ABT : 55.80 (-0.57%)
IME.CN : 0.195 (+8.33%)
IMEXF : 0.1600 (+1.33%)
MDT : 82.34 (-0.39%)
Imagin Medical Scientific Advisor Attends Society of International Urology Meeting

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in minimally...

IME.CN : 0.195 (+8.33%)
IMEXF : 0.1600 (+1.33%)
Imagin Medical Scientific Advisor Attends Society of International Urology Meeting

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in minimally...

IME.CN : 0.195 (+8.33%)
IMEXF : 0.1600 (+1.33%)
The Medical Device Market Just Keeps Going Strong

USA News Group - In spite of lawmakers' inability to determine direction for healthcare, medical device companies continue to be some of the strongest performers this year. Companies being rewarded for...

IME.CN : 0.195 (+8.33%)
BSX : 28.47 (-1.15%)
IMEXF : 0.1600 (+1.33%)
BDX : 224.23 (-1.15%)
BAX : 64.04 (-0.33%)
Urologists Invest in Imagin Medical Private Placement

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive surgery;...

IME.CN : 0.195 (+8.33%)
IMEXF : 0.1600 (+1.33%)
Urologists Invest in Imagin Medical Private Placement

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive surgery;...

IME.CN : 0.195 (+8.33%)
IMEXF : 0.1600 (+1.33%)
Imagin Medical, a Medical Imaging Company for Early Cancer Detection, Announces $600,000 Non-Brokered Private Placement - Video News Alert on Investmentpitch.com

Imagin Medical (CSE: IME) (OTC Pink: IMEXF) (FSE: DPD1), a medical imaging company, has announced a non-brokered private placement. The company plans to raise gross proceeds of up to $600,000 from the...

IME.CN : 0.195 (+8.33%)
IMEXF : 0.1600 (+1.33%)
IIROC Trade Resumption - IME

Trading resumes in:

IMEXF : 0.1600 (+1.33%)
IIROC Trading Halt - IME

The following issues have been halted by IIROC:

IMEXF : 0.1600 (+1.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Key Turning Points

2nd Resistance Point 0.1785
1st Resistance Point 0.1682
Last Price 0.1600
1st Support Level 0.1373
2nd Support Level 0.1167

See More

52-Week High 0.1930
Last Price 0.1600
Fibonacci 61.8% 0.1223
Fibonacci 50% 0.1004
Fibonacci 38.2% 0.0785
52-Week Low 0.0078

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart